Oncimmune Investors - ONC

Oncimmune Investors - ONC

[ADVERT]
Best deals to access real time data!
Level 2 Basic
Monthly Subscription
for only
£62.08
Silver
Monthly Subscription
for only
£17.37
UK/US Silver
Monthly Subscription
for only
£30.59
VAT not included
Stock Name Stock Symbol Market Stock Type
Oncimmune Holdings Plc ONC London Ordinary Share
  Price Change Price Change % Stock Price Last Trade
0.00 0.0% 168.00 08:00:11
Open Price Low Price High Price Close Price Previous Close
168.00
more quote information »
Industry Sector
HEALTH CARE EQUIPMENT & SERVICES

Top Investor Posts

DateSubject
09/6/2021
09:10
homebrewruss: Recording and Q&A now available from yesterday hTTps://www.investormeetcompany.com/investor/meeting/fy2021-end-of-year-trading-update
08/6/2021
17:13
pugugly: IMC Useful presentation with useful revene figures - Has been recorded and well worth a listen (imo) if a holder or a potential investor
08/6/2021
11:48
homebrewruss: Latest proactive interview hTTps://www.youtube.com/watch?v=ManVu25RJ2w&ab_channel=Proactive and ONC also presenting on investor meet later today at 4.30pm hTTps://www.investormeetcompany.com/oncimmune-holdings-plc/register-investor
08/6/2021
11:13
someuwin: N+1 Singer Trading update reaffirms positive outlook A comprehensive FY’21 (May Y/E) trading statement touts a strong FY’21 outturn in line with our expectations that shows 8x topline growth, building strength in the ImmunoINSIGHTS service business and sets the tone for future upgrades. We leave estimates unchanged, but believe forecasts are prudently pitched with risk to the upside. Notably Investors should take confidence in that management believes that, eight days into the new financial year and a strong start to FY’22, it has visibility on up to 50% of our current FY’22 ImmunoINSIGHTS revenue estimate (£9.4m) and has used today’s statement to reiterate confidence in meeting expectations and delivering maiden profitability in FY’22. Refreshing our valuation analysis implies an intrinsic value of 271p, we reiterate Oncimmune as a Best Idea for 2021...
28/5/2021
07:43
someuwin: ("Oncimmune" or the "Company") Notice of FY21 Trading Update Oncimmune Holdings plc (AIM: ONC.L), the leading global immunodiagnostics group, announces that it will issue a trading update for the year ended 31 May 2021 on 8 June 2021. Analyst and investor presentations Dr Adam M Hill, Chief Executive Officer and Matthew Hall, Chief Financial Officer will host an online presentation for analysts at 11:30am BST on 8 June 2021. For registration details please contact Alexander Davis of FTI Consulting at Alexander.Davis@fticonsulting.com or 020 3727 1000. Dr Adam M Hill and Matthew Hall will also host a live presentation on Investor Meet Company at 4:30pm BST on 8 June 2021 which will be open to all existing Oncimmune shareholders and potential new investors. Access to Investor Meet Company is free and interested parties are invited to register their attendance on the following link: https://www.investormeetcompany.com/oncimmune-holdings-plc/register-investor Investors who already follow Oncimmune Holdings plc on the Investor Meet Company platform will automatically be invited. Questions can be submitted pre-event via your Investor Meet Company dashboard up until 9:00am BST the day before the meeting or at any time during the live presentation.
15/2/2021
16:55
pugugly: Presentation now on - Is being recorded - so (imo) well worth as listen if not able to make it now= Investor meet company https://www.investormeetcompany.com/
12/11/2020
15:36
brummy_git: Find out here my latest investor views wrt ground-breaking immunodiagnostics firm, OncimmuneECDT. hxxps://www.linkedin.com/posts/paul-hill-a5994116_onc-activity-6732676254471909376-MJI8
31/7/2020
07:59
timbo003: They gave investors a heads up on this news at last night's Proactiveinvestor presentation, there were a couple of good Q&As at the end 😉 https://youtu.be/KGfO_FEasaQ?t=4219
31/8/2016
11:23
ascov: Short write up in current edition of Investors Chronicle page 58
ADVFN Advertorial
Your Recent History
LSE
ONC
Oncimmune
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20211021 07:39:10